263 related articles for article (PubMed ID: 19661765)
1. Transdermal estradiol for postpartum depression: a promising treatment option.
Moses-Kolko EL; Berga SL; Kalro B; Sit DK; Wisner KL
Clin Obstet Gynecol; 2009 Sep; 52(3):516-29. PubMed ID: 19661765
[TBL] [Abstract][Full Text] [Related]
2. Transdermal estradiol for postpartum depression: results from a pilot randomized, double-blind, placebo-controlled study.
Li HJ; Martinez PE; Li X; Schenkel LA; Nieman LK; Rubinow DR; Schmidt PJ
Arch Womens Ment Health; 2020 Jun; 23(3):401-412. PubMed ID: 31372757
[TBL] [Abstract][Full Text] [Related]
3. Transdermal estradiol treatment during breastfeeding: maternal and infant serum concentrations.
Pinheiro E; Bogen DL; Hoxha D; Wisner KL
Arch Womens Ment Health; 2016 Apr; 19(2):409-13. PubMed ID: 25956588
[TBL] [Abstract][Full Text] [Related]
4. [GABAergic approach of postpartum depression: A translational review of literature].
Verbe J; Dubertret C; El-Hage W; Bonnet-Brilhault F; Duriez P
Encephale; 2020 Apr; 46(2):123-134. PubMed ID: 31767256
[TBL] [Abstract][Full Text] [Related]
5. Estradiol modulates anhedonia and behavioral despair in rats and negative affect in a subgroup of women at high risk for postpartum depression.
Schiller CE; O'Hara MW; Rubinow DR; Johnson AK
Physiol Behav; 2013 Jul; 119():137-44. PubMed ID: 23770328
[TBL] [Abstract][Full Text] [Related]
6. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
L'Hermite M
Climacteric; 2017 Aug; 20(4):331-338. PubMed ID: 28301216
[TBL] [Abstract][Full Text] [Related]
7. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study.
Ahokas A; Kaukoranta J; Wahlbeck K; Aito M
J Clin Psychiatry; 2001 May; 62(5):332-6. PubMed ID: 11411813
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 17beta-estradiol on depression: is estrogen deficiency really necessary?
Soares CN; Joffe H; Cohen LS; Almeida OP
J Clin Psychiatry; 2002 May; 63(5):451; author reply 451-2. PubMed ID: 12019671
[No Abstract] [Full Text] [Related]
9. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
[TBL] [Abstract][Full Text] [Related]
10. Intrinsically dysregulated cellular stress signaling genes and gene networks in postpartum depression.
Rudzinskas SA; Goff AC; Mazzu MA; Schiller CE; Meltzer-Brody S; Rubinow DR; Schmidt PJ; Goldman D
Mol Psychiatry; 2023 Jul; 28(7):3023-3032. PubMed ID: 36782063
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Canonico M
Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
[TBL] [Abstract][Full Text] [Related]
12. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
13. A randomized comparative study for the clinical evaluation of hormone replacement by transdermal and oral routes.
Polvani F; Zichella L; Bocci A; Bottiglioni F; Cagnazzo G; Campagnoli C; Carenza L; Cianci S; Danesino V; De Cecco L
Clin Exp Obstet Gynecol; 1991; 18(4):207-13. PubMed ID: 1790601
[TBL] [Abstract][Full Text] [Related]
14. Postpartum depression and vitamin D: A systematic review.
Amini S; Jafarirad S; Amani R
Crit Rev Food Sci Nutr; 2019; 59(9):1514-1520. PubMed ID: 29393662
[TBL] [Abstract][Full Text] [Related]
15. The risk of breast cancer after estrogen and estrogen-progestin replacement.
Bergkvist L; Adami HO; Persson I; Hoover R; Schairer C
N Engl J Med; 1989 Aug; 321(5):293-7. PubMed ID: 2546079
[TBL] [Abstract][Full Text] [Related]
16. Transdermal Estradiol Treatment for Postpartum Depression: A Pilot, Randomized Trial.
Wisner KL; Sit DK; Moses-Kolko EL; Driscoll KE; Prairie BA; Stika CS; Eng HF; Dills JL; Luther JF; Wisniewski SR
J Clin Psychopharmacol; 2015 Aug; 35(4):389-95. PubMed ID: 26061609
[TBL] [Abstract][Full Text] [Related]
17. Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments.
Rajkumar L; Guzman RC; Yang J; Thordarson G; Talamantes F; Nandi S
Breast Cancer Res; 2004; 6(1):R31-7. PubMed ID: 14680498
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of continuous once-a-week combination 17β-Estradiol/Low- or high-dose levonorgestrel transdermal delivery systems in postmenopausal women.
Karara AH; Harrison LI; Melikian AP; Poola N; Morrison D; Bourg D; Bourg L; Zurth C
J Clin Pharmacol; 2014 May; 54(5):520-7. PubMed ID: 24474034
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection of reduced thyroid hormone with increased estrogen and progestogen in postpartum depression.
Li D; Li Y; Chen Y; Li H; She Y; Zhang X; Chen S; Chen W; Qiu G; Huang H; Zhang S
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31406011
[No Abstract] [Full Text] [Related]
20. Oestrogens and progestins for preventing and treating postpartum depression.
Dennis CL; Ross LE; Herxheimer A
Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD001690. PubMed ID: 18843619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
